Question 1

What exactly is Ketanest?

Accepted Answer

Ketanest is an injectable anesthetic containing esketamine (the S(+)-enantiomer of ketamine).
 	It is supplied as a clear, sterile solution in glass vials ready for IV or IM administration.
 	Primarily used for rapid induction of general anesthesia and strong procedural pain relief.
 	Offers a dissociative anesthetic effect where patients feel detached but maintain breathing reflexes.
 	Differs from nasal esketamine (Spravato) as this is the classic injectable hospital-grade formulation.
 	Available in common strengths of 5 mg/ml and 25 mg/ml for flexible dosing.

Question 2

How does Ketanest differ from regular ketamine?

Accepted Answer

Contains only the pure S(+)-esketamine enantiomer, making it approximately 2–3 times more potent than racemic ketamine.
 	Allows effective anesthesia and analgesia at lower doses and smaller injection volumes.
 	Often produces a cleaner emergence with potentially fewer unpleasant side effects from the inactive R-enantiomer.
 	Provides stronger NMDA receptor antagonism per milligram compared to mixed ketamine products.
 	Preferred in settings where precise potency and reduced volume matter.
 	Still shares the same core dissociative, analgesic, and sympathomimetic properties as racemic ketamine.

Question 3

What are the main medical uses for Ketanest?

Accepted Answer

Rapid sequence induction of anesthesia, especially in emergency and trauma settings.
 	Short surgical or procedural sedation where quick onset and recovery are essential.
 	Analgesia for severe acute pain, including burn victims or fracture reductions.
 	Maintenance of anesthesia via continuous infusion for longer procedures.
 	Preferred in patients with hemodynamic instability due to its blood pressure-supporting effects.
 	Useful in situations requiring preservation of airway reflexes and spontaneous breathing.

Question 4

How fast does Ketanest work when injected?

Accepted Answer

Intravenous (IV) bolus: clinical effects begin within 30–60 seconds.
 	Intramuscular (IM) injection: onset occurs in 3–5 minutes.
 	Peak anesthetic effect is usually reached within 1 minute after IV administration.
 	Extremely rapid onset makes it one of the fastest-acting injectable anesthetics available.
 	Ideal for urgent situations such as crash intubations or brief painful procedures.
 	Dissociative state appears almost immediately after effective dosing.

Question 5

How long do the anesthetic effects of Ketanest last?

Accepted Answer

Single IV bolus dose typically produces deep anesthesia for 5–15 minutes.
 	Duration depends on dose: higher doses extend the effect slightly.
 	Recovery to orientation usually occurs within 15–30 minutes after a single dose.
 	Can be prolonged significantly by using a continuous infusion drip.
 	Short duration allows quick patient turnover in emergency departments and operating rooms.
 	Sub-anesthetic doses for analgesia may provide pain relief for 30–60 minutes or longer.
 	Emergence phase (waking up) is generally faster than with many barbiturates or propofol.

Question 6

Does Ketanest cause breathing problems like other anesthetics?

Accepted Answer

Ketanest has a remarkably low risk of respiratory depression compared to opioids, propofol, or barbiturates.
 	It usually preserves spontaneous breathing and protective airway reflexes even at anesthetic doses.
 	This makes it safer for use in non-intubated patients or emergency settings without immediate airway control.
 	Apnea is rare unless extremely high doses are given rapidly or combined with other depressants.
 	Patients often maintain adequate ventilation independently during procedures.
 	Still requires monitoring, especially when used with sedatives or in patients with pre-existing respiratory conditions.

Question 7

Will Ketanest increase my blood pressure or heart rate?

Accepted Answer

Yes, Ketanest typically causes a moderate to significant increase in blood pressure and heart rate.
 	This sympathomimetic effect results from stimulation of the sympathetic nervous system.
 	The rise in BP and HR usually peaks within minutes of administration and resolves as the drug wears off.
 	Beneficial in hypotensive or shock patients where maintaining perfusion is critical.
 	May require caution in patients with uncontrolled hypertension, coronary artery disease, or aneurysms.
 	The hemodynamic stimulation is generally dose-dependent and more pronounced than with racemic ketamine in some cases.

Question 8

Can Ketanest cause hallucinations or dissociation?

Accepted Answer

Yes, dissociation is the hallmark effect of Ketanest, creating a dream-like or out-of-body sensation.
 	Hallucinations, vivid dreams, or emergence delirium can occur, especially during recovery.
 	These effects are more common at higher (anesthetic) doses than at sub-anesthetic analgesic doses.
 	The experience is usually short-lived, lasting only during the active drug effect.
 	Co-administration of a benzodiazepine (e.g., midazolam) often reduces the intensity of unpleasant emergence phenomena.
 	Most users describe the dissociative state as detached rather than frightening, but individual reactions vary.

Question 9

Is Ketanest suitable for pain relief outside of surgery?

Accepted Answer

Yes, at lower (sub-anesthetic) doses, Ketanest provides potent analgesia for acute and chronic pain.
 	Effective for severe pain conditions like trauma, burns, neuropathic pain, or opioid-resistant cases.
 	Offers rapid-onset pain relief without significant respiratory depression.
 	Injectable format suits hospital, clinic, or emergency use rather than home self-administration.
 	Duration of analgesia from a single bolus is typically 30–60 minutes or longer with infusion.
 	Can be an adjunct to reduce opioid requirements in multimodal pain protocols.
 	Requires careful dosing to balance pain relief with potential psychomimetic side effects.

Question 10

What vial sizes do we offer for Ketanest at Medical Pharmacy?

Accepted Answer

We stock the most commonly requested concentrations: 5 mg/ml and 25 mg/ml esketamine solutions.
 	Available vial/ampoule sizes include 2 ml, 5 ml, 10 ml, and 20 ml formats.
 	5 mg/ml vials are ideal for lower-dose analgesia or pediatric applications.
 	25 mg/ml vials suit induction of anesthesia or higher-dose requirements with smaller injection volumes.
 	All packaging is sterile, single-use glass vials or ampoules with tamper-evident seals.
 	Quantities can be selected during checkout to match your specific needs.
 	We ensure authenticity and proper cold-chain handling during storage and shipping.

Question 11

How should Ketanest be stored properly?

Accepted Answer

Store vials at controlled room temperature between 15–30°C (59–86°F).
 	Keep protected from direct light—use the original carton or opaque storage.
 	Never freeze the solution, as freezing can damage the formulation and reduce potency.
 	Do not use if the solution appears cloudy, discolored, or contains particles.
 	Shelf life is typically 24–36 months when stored correctly (check expiry on vial).
 	Once opened, use immediately and discard any unused portion for sterility.
 	Avoid exposure to extreme heat or direct sunlight during transport or storage.

Question 12

Is Ketanest safe for repeated or continuous use?

Accepted Answer

Yes, Ketanest can be safely used repeatedly or via continuous infusion under medical supervision.
 	Continuous IV infusion is common for prolonged anesthesia or sedation in ICU settings.
 	Tolerance may develop with frequent or high-dose repeated use, requiring dose increases.
 	Monitor for cumulative psychomimetic effects (dissociation, hallucinations) over time.
 	Liver and kidney function should be checked during extended administration.
 	Emergence reactions can become more pronounced with repeated exposure in some individuals.
 	Always titrate carefully and combine with adjuncts (e.g., benzodiazepines) when needed.

Question 13

What side effects should I watch for with Ketanest?

Accepted Answer

Most common: transient increase in blood pressure and heart rate.
 	Dissociative effects: feeling detached, dream-like state, or out-of-body sensation.
 	Emergence phenomena: vivid dreams, hallucinations, confusion, or agitation during recovery.
 	Nausea and vomiting can occur, though less frequent than with some other agents.
 	Dizziness, double vision, or nystagmus (eye movements) during active effect.
 	Rare but serious: laryngospasm, hypersalivation, or transient apnea at very high doses.
 	Side effects are usually dose-dependent and resolve quickly after the drug wears off.

Question 14

Can Ketanest be combined with other medications?

Accepted Answer

Frequently combined with midazolam or other benzodiazepines to blunt emergence reactions.
 	Pairs well with opioids for enhanced multimodal analgesia while reducing opioid needs.
 	Can be used alongside muscle relaxants during rapid sequence intubation.
 	Avoid combining with other CNS depressants (e.g., high-dose propofol) without airway protection.
 	Caution with sympathomimetics or MAOIs due to amplified hemodynamic effects.
 	Compatible with most IV fluids and many antiemetics for procedural use.
 	Always consider individual patient factors and potential drug interactions.

Question 15

How does Ketanest compare to propofol for anesthesia?

Accepted Answer

Ketanest supports or increases blood pressure; propofol typically causes hypotension.
 	Provides strong analgesia; propofol offers almost none.
 	Lower risk of respiratory depression and better preservation of airway reflexes with Ketanest.
 	Faster emergence and recovery profile in many short procedures with Ketanest.
 	Propofol delivers smoother, deeper sedation with less psychomimetic side effects.
 	Ketanest is preferred in hemodynamically unstable or trauma patients.
 	Propofol is often chosen for longer cases or when complete immobility is required.

Specification	Details	Typical Values/Options	Additional Notes
Active Ingredient	Esketamine (S(+)-enantiomer of ketamine)	Esketamine hydrochloride	More potent enantiomer than racemic ketamine, faster onset in anesthetic use
Strength/Concentration	5 mg/ml or 25 mg/ml	5 ml, 10 ml, 20 ml vials	5 mg/ml for lower-dose applications; 25 mg/ml for induction/maintenance
Formulation	Injectable solution (clear, colorless)	Sterile, preservative-free options	Ready for IV/IM administration; pH adjusted for stability
Primary Medical Uses	Induction of anesthesia, analgesia, procedural sedation	General anesthesia, emergency settings	Maintains airway reflexes better than many alternatives
Onset of Action	Very rapid	30–60 seconds IV; 3–5 minutes IM	Ideal for short procedures or emergencies
Duration of Effect	Short-acting	5–15 minutes single dose (anesthetic)	Can be extended with infusion; sub-anesthetic doses longer for other effects
Route of Administration	Intravenous (IV), Intramuscular (IM)	Bolus or continuous infusion	Not oral or nasal in this formulation (unlike Spravato)
Common Packaging	Glass vials, ampoules	Single-use sterile vials	Tamper-evident seals for authenticity
Storage Requirements	Protect from light, room temperature (15–30°C)	Do not freeze	Stable for extended periods when stored properly
Side Effects Profile	Dissociation, increased BP/HR, hallucinations possible	Dose-dependent	Sympathomimetic effects; lower respiratory depression risk than opioids

Feature	Ketanest (Esketamine)	Racemic Ketamine (e.g., Ketalar)	Propofol	Midazolam
Active Compound	S(+)-Ketamine (pure enantiomer)	Racemic mixture (S & R ketamine)	GABA agonist	Benzodiazepine
Potency	Higher (approx. 2–3x more potent)	Standard potency	High potency anesthetic	Sedative/hypnotic, lower anesthetic potency
Onset Time (IV)	30–60 seconds	30–60 seconds	30–45 seconds	1–5 minutes
Duration (single dose)	5–15 minutes	5–15 minutes	3–10 minutes	30–60 minutes
Analgesic Properties	Strong	Strong	Minimal	Minimal
Respiratory Depression	Low	Low	Moderate to high	Moderate
Hemodynamic Effects	Increases BP & HR	Increases BP & HR	Decreases BP	Minimal changes
Common Use Case	Anesthesia induction, short procedures	Anesthesia, pain management	Sedation in ICU/OR	Sedation, anxiolysis
Hallucinogenic Potential	Moderate (dose-dependent)	Higher	Low	Low
Availability (Medical Pharmacy)	Yes, no prescription needed	Yes, no prescription needed	Limited (strict controls)	Limited

Buy Ketanest online

Buy Ketanest online

Description

Where to buy Ketanest online

Buy Ketanest online

Advanced Ketamine Anesthetic Options

Additional information

Reviews

INFORMATIONS

CATEGORIES

BEST SELLING

RECENT PRODUCTS

Buy Ketanest online

Description

Where to buy Ketanest online

Buy Ketanest online

Advanced Ketamine Anesthetic Options

Additional information

Reviews

Related products

Buy Calypsol online

Buy Ketalar online

Buy tiletamine online

Buy Ketamine Crystal Powder online